Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2008-05-29

Clinical Trial Update: Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating steroids for maintenance of remission in proliferative lupus nephritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Steroids (glucocorticoids) (glucocorticoids)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Lupus Nephritis | Phase 3 | Status: WITHDRAWN